Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2026-03-02 @ 8:17 AM
Study NCT ID:
NCT01709500
Status:
COMPLETED
Last Update Posted:
2015-10-28
First Post:
2012-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-08
First Submit QC Date:
None
Study First Post Date:
2012-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-29
Results First Submit QC Date:
None
Results First Post Date:
2015-10-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-02-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-09-29
Last Update Post Date:
2015-10-28
Last Update Post Date Type:
ESTIMATED